Advancing Technology in Clinical Trials

With increasing pressure to overcome drug development challenges and advance drugs to market faster and with greater efficiency, sponsor expectations of CROs and their services are running high.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Blog

ICH E6(R3), Demystified Part 3: Quality Tolerance Limits

Proactively Identifying and Managing Risks Quality Tolerance Limits (QTLs) were mandated in ICH E6(R2). Reflecting industry...

Blog

ICH E6(R3), Demystified Part 2 | Defining Critical-to-Quality

Ethical and Actionable Trial Outcomes ICH E6(R3) is more than just an update to Good Clinical...

Press Release

CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth

King of Prussia, PA – January 12, 2026 – CluePoints, provider of leading statistical and AI-driven...